How many 8-K filings has Sanara Medtech Inc. filed?

Sanara Medtech Inc. (SMTI) has 22 8-K (Current Event Report) filings on record, spanning Feb 2024 to Mar 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Sanara Medtech Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Sanara Medtech Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Sanara Medtech Inc. (SMTI) — 8-K Filings

All 8-K filings from Sanara Medtech Inc.. Browse 22 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (22)

Sanara MedTech Files 8-K on Financial Results — Mar 24, 2026
Sanara MedTech Inc. filed an 8-K on March 24, 2026, reporting under Item 2.02, "Results of Operations and Financial Condition." This indicates the company is li
8-K Filing — Nov 26, 2025
Sanara MedTech Announces Board & Executive Changes — Sep 2, 2025 Risk: medium
Sanara MedTech Inc. announced on August 27, 2025, changes in its board of directors and executive compensation. The filing details the departure of certain offi
8-K Filing — May 28, 2025
Sanara MedTech Announces Board and Executive Changes — May 23, 2025 Risk: medium
Sanara MedTech Inc. announced on May 19, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of ce
Sanara MedTech Files 8-K on Financials — May 14, 2025 Risk: low
Sanara MedTech Inc. filed an 8-K on May 14, 2025, reporting on its Results of Operations and Financial Condition, and submitting Financial Statements and Exhibi
Sanara MedTech Files 8-K: Reg FD & Financials — Apr 22, 2025 Risk: low
Sanara MedTech Inc. filed an 8-K on April 22, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as W
Sanara MedTech Completes Acquisition — Apr 4, 2025 Risk: medium
On April 1, 2025, Sanara MedTech Inc. reported the completion of an acquisition. The company, formerly known as Wound Management Technologies, Inc., is involved
Sanara MedTech Enters Material Definitive Agreement — Jan 22, 2025 Risk: medium
Sanara MedTech Inc. announced on January 16, 2025, that it entered into a material definitive agreement. The company, formerly known as Wound Management Technol
Sanara MedTech Files 8-K on Financials — Jan 21, 2025 Risk: low
Sanara MedTech Inc. filed an 8-K on January 21, 2025, reporting on its results of operations and financial condition. The filing includes financial statements a
Sanara MedTech Files 8-K with Financials — Dec 4, 2024 Risk: low
Sanara MedTech Inc. filed an 8-K on December 4, 2024, reporting information under Regulation FD and including financial statements and exhibits. The company, fo
Sanara MedTech Announces Board & Executive Compensation Changes — Oct 7, 2024 Risk: medium
Sanara MedTech Inc. announced on October 4, 2024, a change in its board of directors and executive compensation arrangements. The filing details the departure o
Sanara MedTech Appoints New Directors, Director Departs — Sep 23, 2024 Risk: medium
Sanara MedTech Inc. announced on September 19, 2024, the departure of Director Michael J. Collins. The company also elected two new directors, David L. Johnson
Sanara MedTech Files 8-K — Sep 11, 2024 Risk: low
Sanara MedTech Inc. filed an 8-K on September 11, 2024, reporting events that occurred on September 10, 2024. The filing includes information related to Regulat
Sanara MedTech Files 8-K with Financial Updates — Jun 20, 2024 Risk: low
Sanara MedTech Inc. filed an 8-K on June 20, 2024, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company
Sanara MedTech Announces Director Changes and Officer Appointments — Jun 18, 2024 Risk: medium
Sanara MedTech Inc. announced on June 12, 2024, the departure of Director David L. Johnson and the election of new directors, including Dr. Michael J. Mulroy an
Sanara MedTech Files 8-K for Corporate Changes — Jun 17, 2024 Risk: low
Sanara MedTech Inc. filed an 8-K on June 17, 2024, reporting events that occurred on June 12, 2024. The filing indicates changes to the company's articles of in
Sanara MedTech Appoints New CFO, Grants Stock Options — May 30, 2024 Risk: medium
Sanara MedTech Inc. announced on May 29, 2024, the appointment of Michael J. O'Leary as Chief Financial Officer, effective June 3, 2024. O'Leary will receive an
Sanara MedTech Terminates Agreement, Incurs Obligation — Apr 18, 2024 Risk: medium
Sanara MedTech Inc. announced on April 17, 2024, the termination of a material definitive agreement and the creation of a direct financial obligation. The compa
Sanara MedTech Appoints New CFO, Grants Stock Options — Apr 5, 2024 Risk: medium
Sanara MedTech Inc. announced on April 5, 2024, the appointment of Michael J. O'Leary as Chief Financial Officer, effective April 8, 2024. O'Leary will receive
Sanara MedTech Changes Fiscal Year End — Mar 22, 2024 Risk: low
Sanara MedTech Inc. filed an 8-K on March 22, 2024, reporting a change in its fiscal year end to December 31st. This filing also includes financial statements a
Sanara MedTech Files 8-K on Financial Condition — Feb 22, 2024 Risk: low
Sanara MedTech Inc. filed an 8-K on February 22, 2024, reporting on its results of operations and financial condition. The filing indicates the company's curren

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX